Tend to agree with valuation, however all I can find using old valuation metrics is a few unloved dogs that appear to have slow growth and no chance of real share price appreciation.
Have sat and watched all these over priced stocks keep getting more expensive. Have pulled the trigger too quickly on their decline including PME who I believe is worthy of a premium to old traditional valuation metrics, how much is what the market is arguing about at the moment.
In any case I hope you don’t get to buy PME at mid teens although at current rates of decline we’ll be there in a week or two. Then I believe the amount of money looking for a home will ensure any overshot decline will be temporary.
Ann: Annual Report 2019, page-79
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$179.02 |
Change
1.260(0.71%) |
Mkt cap ! $18.70B | |||
| Open | High | Low | Value | Volume |
| $177.38 | $181.28 | $177.00 | $24.00M | 133.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 121 | $179.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $179.25 | 275 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PME (ASX) Chart |